PDE6D and Alzheimer disease: Taking into account that the MAPK pathway is also involved in Tau hyperphosphorylation, inhibition of PDE6δ/Rap1 interaction in the mice models of AD hAPP*PS1 and hTAU reduced ERK cascade activation and Tau phosphorylation in different residues in vivo, which resulted in the rescue of behavioral deficits [45].